Treatment Options for HIV-Associated Tuberculosis

Onyebujoh, Philip Chukwuka; Ribeiro, Isabela; Whalen, Christopher Curtis
August 2007
Journal of Infectious Diseases;8/15/2007 Supplement, Vol. 196, pS35
Academic Journal
The vicious interaction between the human immunodeficiency virus (HIV) infection and tuberculosis (TB) pandemics poses special challenges to national control programs and individual physicians. Although recommendations for the treatment of TB in HIV-infected patients do not significantly differ from those for HIV-uninfected patients, the appropriate management of HIV-associated TB is complicated by health system issues, diagnostic difficulties, adherence concerns, overlapping adverse-effect profiles and drug interactions, and the occurrence of paradoxical reactions after the initiation of effective antiretroviral therapy. In this article, recommended treatment strategies and novel approaches to the management of HIV-associated TB are reviewed, including adjuvant treatment and options for treatment simplification. A focused research agenda is proposed in the context of the limitations of the current knowledge framework.


Related Articles

  • Pharmacists as providers of HIV pre-exposure prophylaxis. Bruno, Christine; Saberi, Parya // International Journal of Clinical Pharmacy;Dec2012, Vol. 34 Issue 6, p803 

    The efficacy of HIV pre-exposure prophylaxis (PrEP) has been demonstrated in four clinical trials to date; however, the success of PrEP is largely dependent on high levels of medication adherence. Due to their extensive experience and expertise in medication adherence counseling, as well as...

  • Adherence to anti-retroviral therapy among HIV patients in Bangalore, India. Cauldbeck, Mary B.; O'Connor, Catherine; O'Connor, Mortimer B.; Saunders, Jean A.; Rao, Bhimasena; Mallesh, V. G.; Praveen Kumar, Nagendrappa Kotehalappa; Mamtha, Gurushanthappa; McGoldrick, Claire; Laing, Robert B. S.; Satish, Kadappa Shivappa // AIDS Research & Therapy;2009, Vol. 6, Special section p1 

    Introduction: Human Immunodeficiency Virus (HIV) has an estimated prevalence of 0.9% in India (5.2 million). Anti-retroviral drugs (ARV) are the treatments of choice and non-adherence is an important factor in treatment failure and development of resistance, as well as being a powerful predictor...

  • THE USING OF ARV PATTERN TO PATIENTS ON HIV/AIDS IN UPIPI Dr. SOETOMO HOSPITAL, SURABAYA, JANUARY - JUNE 2011. Sari, Retno Juwita; Srihartini, Indah; Triyono, Erwin Astha // Folia Medica Indonesiana;2013, Vol. 49 Issue 3, p182 

    This study aims to determine how patterns of use of antiretroviral agents in HIV/AIDS patients in UPIPI RSUD Dr. Soetomo during January-June 2011. The method of the study conducted retrosprektif observational data and analyzed using descriptive. The results showed than 202 patients, ARV regimens...

  • HIV Infection: The Role of Primary Care. ROMANELLI, FRANK; MATHENY, SAMUEL C. // American Family Physician;11/1/2009, Vol. 80 Issue 9, p946 

    Human immunodeficiency virus infection was first documented in the United States in 1981. Since that time, significant strides have been made in the prevention and treatment of the condition. Screening is paramount in identifying early infection and is now a routine component of primary care....

  • Where to Start?  // Guide;May2006, Vol. 26 Issue 5, p77 

    The article states that the use of antiretroviral therapy for HIV patients still faces challenges, such as major adverse effects, difficulties of patients to comply with treatment regimen, and antiretroviral drug resistance. Patients are encouraged to visit www.hivinsite.org to obtain...

  • Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy. Reid, S. E.; Reid, C. A.; Vermund, S. H. // International Journal of STD & AIDS;Nov2004, Vol. 15 Issue 11, p713 

    Declining drug costs and increases in international donor interest are leading to greater availability of antiretroviral treatment programmes for persons living with the human immunodeficiency virus in parts of sub-Saharan Africa. Ensuring adequate adherence to antiretroviral drug therapy is one...

  • Clinically significant interactions between antiretroviral and co-prescribed drugs for HIV-infected children: profiling and comparison of two drug databases. Oshikoya, Kazeem A.; Oreagba, Ibrahim A.; Ogunleye, Olayinka O.; Lawal, Saheed; Senbanjo, Idowu O. // Therapeutics & Clinical Risk Management;2013, Vol. 9, p215 

    Background: Drug-drug interactions are an important therapeutic challenge among human immunodeficiency virus-infected patients. Early recognition of drug-drug interactions is important, but conflicts do exist among drug compendia on drug interaction information. We aimed to evaluate the...

  • Has HAART failed? Soresen, Suellyn J.; Busti, Anthony J. // Drug Topics;5/16/2005, Vol. 149 Issue 10, DRUG TOPIC FOR THE... p8 

    Offers advice concerning the condition of an HIV-positive patient who is experiencing virologic failure due to antiretroviral drug interactions. Types of antiretroviral agents being administered to the patient; Increase in drug concentration and toxicity risk; Need for a potent and effective...

  • Antiretrovirals/fluoxetine/isoniazid.  // Reactions Weekly;9/19/2009, Issue 1270, p7 

    The article describes three cases of hyperactive delirium induced by antiretroviral therapy in three HIV-positive children with cerebral and/or cellebellar atrophy. It provides an overview of the antiretrovirals that the patients received. It relates that one of the patients developed serotonin...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics